Literature DB >> 6699407

Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum.

D R Hill, J J Burge, R D Pearson.   

Abstract

To define the potential role of complement and antibody in host defense against Giardia lamblia, the effect of human serum on axenically cultured G. lamblia trophozoites was studied. Sera from patients without a history of giardiasis and with no detectable antibody by an indirect immunofluorescence antibody (IFA) assay (IFA titers less than 1:2) killed from 8 to 76% of trophozoites (n = 23 sera). Whereas less than 10% of parasites incubated in phosphate-buffered saline alone were killed, 16 sera killed from 10 to 25% and six sera killed from 25 to 75%. One serum with an anti-G lamblia antibody titer of 1:128 killed greater than 98% of the parasites. The complement dependency of killing was demonstrated by abrogation of the lethal effect when serum was chelated with EDTA (7 mM) or was heat-inactivated (56 degrees C, 30 min), and, in an immunofluorescence assay, by detection of C3 on parasites killed by normal serum. When the classical complement pathway was selectively blocked by using serum chelated with Mg+2 (2 mM)-EGTA (8 mM), or serum congenitally deficient for the second component of complement, there was no killing; thus, killing was dependent on the presence of an intact classical pathway. In each of three sera from donors with negative IFA titers, an absorbable factor specific for G. lamblia, possibly antibody not detected by IFA, was required for classical pathway activation. To determine if alteration of the surface of G. lamblia would render it an activator of the alternative pathway of complement, trophozoites were studied after cell death or after treatment with neuraminidase or trypsin. In MgEGTA-chelated serum, dead trophozoites activated the alternative pathway as determined by consumption of Factor B and deposition of C3 on their surface. In contrast, untreated or enzyme-treated living parasites did not activate the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699407

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 2.  Immunopathology of giardiasis.

Authors:  M J Farthing
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Immunoglobulin M-dependent classical complement pathway activation in killing of Pentatrichomonas hominis.

Authors:  M F Shaio; J G Chen
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 4.  Immune response to Giardia duodenalis.

Authors:  G Faubert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 5.  The Intersection of Immune Responses, Microbiota, and Pathogenesis in Giardiasis.

Authors:  Marc Y Fink; Steven M Singer
Journal:  Trends Parasitol       Date:  2017-08-19

6.  vsp gene expression by Giardia lamblia clone GS/M-83-H7 during antigenic variation in vivo and in vitro.

Authors:  M Bienz; M Siles-Lucas; P Wittwer; N Müller
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 7.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

8.  Ingestion of Giardia lamblia trophozoites by human mononuclear phagocytes.

Authors:  D R Hill; R D Pearson
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

9.  Serum antibodies to Giardia lamblia by age in populations in Colorado and Thailand.

Authors:  E N Janoff; D N Taylor; P Echeverria; M P Glode; M J Blaser
Journal:  West J Med       Date:  1990-03

Review 10.  The biology of Giardia spp.

Authors:  R D Adam
Journal:  Microbiol Rev       Date:  1991-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.